Drug Type Small molecule drug |
Synonyms Amifloxacin (USAN/INN) + [3] |
Target |
Mechanism Top II inhibitors(Topoisomerase II inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC17H23FN4O6S |
InChIKeyIKMAVYOHGHYOIZ-UHFFFAOYSA-N |
CAS Registry88036-80-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D02902 | - | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Gram-Negative Bacterial Infections | Phase 2 | JP | - | |
Gram-Negative Bacterial Infections | Phase 2 | - | - | |
Gram-Negative Bacterial Infections | Phase 2 | - | - | |
Gram-Negative Bacterial Infections | Phase 2 | US | - | |
Shock, Septic | Phase 2 | - | - | |
Shock, Septic | Phase 2 | - | - | |
Shock, Septic | Phase 2 | US | - | |
Urinary Tract Infections | Phase 2 | US | - | |
Urinary Tract Infections | Phase 2 | - | - | |
Urinary Tract Infections | Phase 2 | - | - |